Eosinophil cationic protein (ECP):: molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease

被引：2
|
作者：
Venge, P
Byström, J
Carlson, M
Håkansson, L
Karawacjzyk, M
Peterson, C
Sevéus, L
Trulson, A
机构：
[1] Uppsala Univ, Dept Med Sci, Uppsala, Sweden
[2] Pharmacia & Upjohn Diagnost AB, Uppsala, Sweden
来源：
CLINICAL AND EXPERIMENTAL ALLERGY | 1999年 / 29卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1172 / 1186
页数：15
相关论文
共 50 条
  • [21] The use of serum eosinophil cationic protein (ECP) in the management of steroid therapy in chronic asthma
    Wever, AMJ
    WeverHess, J
    Hermans, J
    CLINICAL AND EXPERIMENTAL ALLERGY, 1997, 27 (05): : 519 - 529
  • [22] Eosinophil cationic protein (ECP) polymorphisms and association with asthma, s-ECP levels and related phenotypes
    Munthe-Kaas, M. C.
    Gerritsen, J.
    Carlsen, K. H.
    Undlien, D.
    Egeland, T.
    Skinningsrud, B.
    Torres, T.
    Carlsen, K. L.
    ALLERGY, 2007, 62 (04) : 429 - 436
  • [23] Effect of eosinophil cationic protein (ECP) on Hodgkin lymphoma cell lines
    Glimelius, Ingrid
    Rubin, Jenny
    Fischer, Marie
    Molin, Daniel
    Amini, Rose-Marie
    Venge, Per
    Enblad, Gunilla
    EXPERIMENTAL HEMATOLOGY, 2011, 39 (08) : 850 - 858
  • [24] THE CYTOTOXIC EOSINOPHIL CATIONIC PROTEIN (ECP) HAS RIBONUCLEASE-ACTIVITY
    GULLBERG, U
    WIDEGREN, B
    ARNASON, U
    EGESTEN, A
    OLSSON, I
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 139 (03) : 1239 - 1242
  • [25] SERUM MEASUREMENTS OF EOSINOPHIL CATIONIC PROTEIN (ECP) IN BRONCHIAL-ASTHMA
    VENGE, P
    CLINICAL AND EXPERIMENTAL ALLERGY, 1993, 23 : 3 - 7
  • [26] Specific immunotherapy reduces nasal eosinophil cationic protein (ECP) release
    Carlos, AGP
    Branco-Ferreira, MA
    Pereira-Santos, MC
    Palma-Carlos, ML
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S316 - S316
  • [27] Exploring the role of eosinophil cationic protein (ECP) in schizophrenia: Insights and implications
    Obeagu, Emmanuel Ifeanyi
    MEDICINE, 2024, 103 (22) : E38380
  • [28] Evaluation of serum eosinophil cationic protein (ECP) monitoring childhood asthma: ECP as a marker for indication and discontinuation of inhaled steroid therapy.
    Iikura, Y
    Matsumoto, T
    Yoshida, H
    Kanemitsu, T
    Yoshida, H
    Otsuka, T
    Oto, K
    Akai, L
    Akasawa, A
    Matsuda, K
    Ebisawa, M
    Nakamura, H
    Ueno, K
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (01) : S8 - S8
  • [29] Comparison of human eosinophil cationic protein (ECP) and a novel multi-functional peptide derived from ECP
    Kuo, P-H
    Fang, S-L
    Hung, T-J
    Chen, C-J
    Chang, H-H
    Lien, P-C
    Chang, P-L
    ALLERGY, 2013, 68 : 78 - 78
  • [30] EVALUATION OF SERUM EOSINOPHIL CATIONIC PROTEIN (ECP) AS AN INDICATOR OF DISEASE-ACTIVITY IN CHRONIC ASTHMA
    FERGUSON, AC
    BROWN, H
    VAUGHAN, R
    COLE, RT
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 93 (01) : 199 - 199
12345